BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 22322005)

  • 21. HLA alleles and drug hypersensitivity reactions.
    Profaizer T; Eckels D
    Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine Induces Focused T Cell Responses in Resolved Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Cases But Does Not Perturb the Immunopeptidome for T Cell Recognition.
    Mifsud NA; Illing PT; Lai JW; Fettke H; Hensen L; Huang Z; Rossjohn J; Vivian JP; Kwan P; Purcell AW
    Front Immunol; 2021; 12():653710. PubMed ID: 33912179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
    Hung SI; Chung WH; Liu ZS; Chen CH; Hsih MS; Hui RC; Chu CY; Chen YT
    Pharmacogenomics; 2010 Mar; 11(3):349-56. PubMed ID: 20235791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.
    Zhang Y; Wang J; Zhao LM; Peng W; Shen GQ; Xue L; Zheng XX; He XJ; Gong CY; Miao LY
    Eur J Clin Pharmacol; 2011 Sep; 67(9):885-7. PubMed ID: 21424386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.
    Amstutz U; Ross CJ; Castro-Pastrana LI; Rieder MJ; Shear NH; Hayden MR; Carleton BC;
    Clin Pharmacol Ther; 2013 Jul; 94(1):142-9. PubMed ID: 23588310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.
    Chang CC; Too CL; Murad S; Hussein SH
    Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis.
    Khor AH; Lim KS; Tan CT; Wong SM; Ng CC
    Epilepsia; 2014 Nov; 55(11):e120-4. PubMed ID: 25266342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-B∗ 1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population.
    Aggarwal R; Sharma M; Modi M; Garg VK; Salaria M
    Hum Immunol; 2014 Nov; 75(11):1120-2. PubMed ID: 25305458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
    Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD39
    Shen M; Lim JME; Chia C; Ren EC
    Immunobiology; 2020 Jan; 225(1):151868. PubMed ID: 31784043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population.
    Niihara H; Kakamu T; Fujita Y; Kaneko S; Morita E
    J Dermatol; 2012 Jul; 39(7):594-601. PubMed ID: 22211527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China.
    Sun D; Yu CH; Liu ZS; He XL; Hu JS; Wu GF; Mao B; Wu SH; Xiang HH
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):146-150. PubMed ID: 24496695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.
    Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Chen P; Lin SY; Chen WH; Konyoung P; Khunarkornsiri U; Auvichayapat N; Pavakul K; Kulkantrakorn K; Choonhakarn C; Phonhiamhan S; Piyatrakul N; Aungaree T; Pongpakdee S; Yodnopaglaw P
    Epilepsia; 2010 May; 51(5):926-30. PubMed ID: 20345939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.
    Simper GS; Hò GT; Celik AA; Huyton T; Kuhn J; Kunze-Schumacher H; Blasczyk R; Bade-Döding C
    J Immunol Res; 2018; 2018():5086503. PubMed ID: 30302345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.
    Tiamkao S; Jitpimolmard J; Sawanyawisuth K; Jitpimolmard S
    Int J Clin Pharm; 2013 Aug; 35(4):608-12. PubMed ID: 23649893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic predisposition of life-threatening antiepileptic-induced skin reactions.
    Chung WH; Hung SI; Chen YT
    Expert Opin Drug Saf; 2010 Jan; 9(1):15-21. PubMed ID: 20001755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
    Devi K
    Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Drug-Specific CD4
    Jaruthamsophon K; Thomson PJ; Hammond S; Zhang E; Alfirevic A; Sukasem C; Naisbitt DJ; Pirmohamed M
    Chem Res Toxicol; 2023 May; 36(5):757-768. PubMed ID: 37074725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.